← SynDRA
AMYGDALIN
SynDRA canonical compound SYN0011909 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CASP3 |
|---|
| Mechanism of action | Caspase activator |
|---|
All known targets
Mechanisms of action (all sources)
Drug classes
- Antineoplastic Agents, Phytogenic
Cross-references
Synonyms
- D-Amygdalin
- (R)-Amygdalin
- (R)-Laenitrile
- (R)-Amygdaloside
- R-Amygdalin
- NSC 15780
- D(-)-Mandelonitrile-beta-D-gentiobioside
- D-Mandelonitrile-beta-D-glucosido-6-beta-D-glucoside
- Glucoprunasin
- CHEBI:17019
- (-)-D-mandelonitrile beta-D-gentiobioside
- CHEBI:27613
- NSC251222
- RefChem:5553
- Mandelonitrile beta Gentiobioside
- DTXCID701326581
- NSC15780
- Amygdaloside
- MFCD00006598
- C20H27NO11
- amygdaline
- UNII-214UUQ9N0H
- MFCD00866428
- HSDB 3559
- EINECS 249-925-3
- BRN 0066856
- Amygdalin/Vitamin B17
- AMYGDALIN [MI]
- AMYGDALIN [HSDB]
- bmse000139
- AMYGDALIN [WHO-DD]
- 5-17-08-00118 (Beilstein Handbook Reference)
- MLS002473175
- SCHEMBL131406
- orb1305010
- orb3140227
- MSK1532
Look up AMYGDALIN in the interactive SynDRA portal →